PDE5 inhibition rescues mitochondrial dysfunction and angiogenic responses induced by Akt3 inhibition by promotion of PRC expression.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
25 12 2020
Historique:
received: 04 04 2020
revised: 15 10 2020
pubmed: 23 10 2020
medline: 26 3 2021
entrez: 22 10 2020
Statut: ppublish

Résumé

Akt3 regulates mitochondrial content in endothelial cells through the inhibition of PGC-1α nuclear localization and is also required for angiogenesis. However, whether there is a direct link between mitochondrial function and angiogenesis is unknown. Here we show that Akt3 depletion in primary endothelial cells results in decreased uncoupled oxygen consumption, increased fission, decreased membrane potential, and increased expression of the mitochondria-specific protein chaperones, HSP60 and HSP10, suggesting that Akt3 is required for mitochondrial homeostasis. Direct inhibition of mitochondrial homeostasis by the model oxidant paraquat results in decreased angiogenesis, showing a direct link between angiogenesis and mitochondrial function. Next, in exploring functional links to PGC-1α, the master regulator of mitochondrial biogenesis, we searched for compounds that induce this process. We found that, sildenafil, a phosphodiesterase 5 inhibitor, induced mitochondrial biogenesis as measured by increased uncoupled oxygen consumption, mitochondrial DNA content, and voltage-dependent anion channel protein expression. Sildenafil rescued the effects on mitochondria by Akt3 depletion or pharmacological inhibition and promoted angiogenesis, further supporting that mitochondrial homeostasis is required for angiogenesis. Sildenafil also induces the expression of PGC-1 family member PRC and can compensate for PGC-1α activity during mitochondrial stress by an Akt3-independent mechanism. The induction of PRC by sildenafil depends upon cAMP and the transcription factor CREB. Thus, PRC can functionally substitute during Akt3 depletion for absent PGC-1α activity to restore mitochondrial homeostasis and promote angiogenesis. These findings show that mitochondrial homeostasis as controlled by the PGC family of transcriptional activators is required for angiogenic responses.

Identifiants

pubmed: 33087445
pii: S0021-9258(17)50684-5
doi: 10.1074/jbc.RA120.013716
pmc: PMC7939459
pii:
doi:

Substances chimiques

Phosphodiesterase 5 Inhibitors 0
Transcription Factors 0
peroxisome-proliferator-activated receptor-gamma coactivator-1 0
AKT3 protein, human EC 2.7.11.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
Cyclic Nucleotide Phosphodiesterases, Type 5 EC 3.1.4.35
PDE5A protein, human EC 3.1.4.35

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18091-18104

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM103499
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL084565
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007260
Pays : United States

Informations de copyright

© 2020 Corum et al.

Déclaration de conflit d'intérêts

Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.

Références

Int J Biochem Cell Biol. 2009 Oct;41(10):1790-804
pubmed: 19703650
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7111-6
pubmed: 12764228
Adv Physiol Educ. 2006 Dec;30(4):145-51
pubmed: 17108241
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12865-70
pubmed: 25136137
Science. 2012 Aug 31;337(6098):1062-5
pubmed: 22936770
J Pharmacol Exp Ther. 2013 Dec;347(3):626-34
pubmed: 24042162
Cold Spring Harb Perspect Biol. 2011 Jul 01;3(7):
pubmed: 21628427
Biochim Biophys Acta. 2005 Sep 30;1709(3):214-9
pubmed: 16140258
J Biol Chem. 2011 Nov 18;286(46):39715-25
pubmed: 21937425
Biochim Biophys Acta. 2011 Jul;1813(7):1269-78
pubmed: 20933024
Dev Biol. 2013 Jan 1;373(1):163-75
pubmed: 23103584
J Cardiovasc Pharmacol. 2010 Apr;55(4):308-16
pubmed: 20422735
Cardiovasc Res. 2010 Oct 1;88(1):58-66
pubmed: 20558442
Acta Biochim Biophys Sin (Shanghai). 2016 May;48(5):447-53
pubmed: 26972278
FASEB J. 2008 Sep;22(9):3264-75
pubmed: 18524868
Nat Rev Mol Cell Biol. 2011 Jan;12(1):9-14
pubmed: 21179058
Science. 2008 May 2;320(5876):661-4
pubmed: 18388260
Cell Metab. 2014 Feb 4;19(2):246-58
pubmed: 24506866
Cell. 2013 Aug 1;154(3):651-63
pubmed: 23911327
Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16507-12
pubmed: 15545607
J Biol Chem. 2013 Mar 22;288(12):8004-8015
pubmed: 23364789
Science. 2003 Feb 7;299(5608):896-9
pubmed: 12574632
Clinics (Sao Paulo). 2011;66(8):1407-12
pubmed: 21915492
Cell Metab. 2013 Dec 3;18(6):908-19
pubmed: 24315374
Am J Respir Crit Care Med. 2004 Jan 15;169(2):227-34
pubmed: 14597480
Development. 2016 Oct 1;143(19):3582-3590
pubmed: 27702786
Trends Cell Biol. 2013 Jul;23(7):311-8
pubmed: 23489877
Biochem J. 2009 Oct 23;424(1):99-107
pubmed: 19740075
Cell. 2009 Aug 21;138(4):628-44
pubmed: 19703392
Cell. 1998 Mar 20;92(6):829-39
pubmed: 9529258
J Biol Chem. 2004 Sep 17;279(38):39593-603
pubmed: 15262994
Trends Biochem Sci. 2011 May;36(5):254-61
pubmed: 21353780
Cell Death Dis. 2014 Jan 09;5:e984
pubmed: 24407237
J Neurosci Res. 2003 Mar 15;71(6):759-62
pubmed: 12605400
Arch Med Sci. 2015 Mar 16;11(1):190-8
pubmed: 25861307
Cell Metab. 2010 Dec 1;12(6):633-42
pubmed: 21109195
Cell. 2012 Mar 16;148(6):1145-59
pubmed: 22424226
FASEB J. 2014 Jan;28(1):395-407
pubmed: 24081905
Free Radic Biol Med. 2010 Apr 1;48(7):905-14
pubmed: 20093177
PLoS One. 2013 Dec 23;8(12):e83049
pubmed: 24376630
J Neurochem. 2001 Oct;79(2):266-77
pubmed: 11677254
Urology. 2000 Jan;55(1):146-50
pubmed: 10654914

Auteurs

Daniel G Corum (DG)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina.

Dorea P Jenkins (DP)

Department of Pathology, Medical University of South Carolina, Charleston, South Carolina.

James A Heslop (JA)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina.

Lacey M Tallent (LM)

Department of Bioengineering, Duke University, Durham, North Carolina.

Gyda C Beeson (GC)

Department of Drug Discovery, Medical University of South Carolina, Charleston, South Carolina.

Jeremy L Barth (JL)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina.

Rick G Schnellmann (RG)

Department of Pharmacy, University of Arizona, Tucson, Arizona.

Robin C Muise-Helmericks (RC)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina. Electronic address: musehelm@musc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH